Sarra Ben Rejeb

Sarra Ben Rejeb

Auto-generated profile, based on publicly available information

Sarra Ben Rejeb

Pathology Department, Security Forces Hospital, Tunis, Tunisia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2021 in Journal of Immunoassay and Immunochemistry
Verified
Journal Article
Closed access
SRSarra Ben Rejeb
Sarra Ben Rejeb
LCLamia Charfi
Lamia Charfi
GSGhada Sahraoui
Ghada Sahraoui
NBNadia Boujelben
Nadia Boujelben
KMKarima Mrad
Karima Mrad
RDRaoudha Doghri
Raoudha Doghri
Langerhans cell histiocytosis (LCH) is a rare disorder of unknown etiopathogenesis. Diagnosis is based on the identification of CD1a positive histiocytic infiltrate. Activation of the mitogen-activated-protein-kinase (MAPK) is constantly observed in LCH and therefore downstream markers such as cyclin D1 may be a useful marker for LCH. The aim of this study was to investigate the expression of cyclin D1 in LCH. We assessed the immunohistochemical expression of cyclin D1 (clone SP4-R) in series of 16 cases of confirmed LCH. Expression of Cyclin D1 was scored as weak, moderate, and strong nuclear staining and results were interpreted by two pathologists. The percentage of positivity was assessed. The mean age of patients was 13.7 years old with a male to female ratio of 1:3. The most common involved site was bone (n = 9; 56,3%), followed by lymph node (n = 5; 31,2%) and skin (n = 2; 12,5%). All cases showed nuclear staining for cyclin D1 with variable intensity. It was assessed moderate in 43,8% (n = 7) and strong in 56,2% (n = 9). The percentage of positive cells was >50% in 13 cases and <50% in 3 cases. Our results have shown that all cases of Langerhans cell histiocytosis from various sites express cyclin D1. This finding may be attributed to MAPK pathway activation that has been described in LCH. Otherwise, cyclin D1 is not significantly expressed in reactive Langerhans cell proliferations. Therefore, cyclin D1 immunohistochemistry may be useful as a diagnostic marker and in excluding non-neoplastic mimics of LCH.

1 January 2021
Verified
Journal Article
Open access
SRSarra Ben Rejeb
Sarra Ben Rejeb
DBDorsaf Beltaifa
Dorsaf Beltaifa
ADAmen Dhaoui
Amen Dhaoui
FDFaten Derbel
Faten Derbel
KBKhadija Bellil
Khadija Bellil
Sweet syndrome (SS), also known as acute febrile neutrophilic dermatosis is a rare cutaneous disorder characterized by specific clinical, biological and microscopic findings. Although the exact cause of SS is still unknown, it may be triggered by infections, malignancies and drugs but also occurring after vaccinations such as bacille calmette guerin vaccination and influenza vaccine. While the recently discovered SARS COV2 vaccines are almost safe, many cutaneous and extracutaneous minor adverse effects are reported. We herein describe the fourth case of Sweet Syndrome induced by SARS-COV2 vaccine.

17 November 2025 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
MLMarwa Lakhal
Marwa Lakhal
SRSarra Ben Rejeb
Sarra Ben Rejeb
AZAlia Zehani
Alia Zehani
SHSlim Haouet
Slim Haouet
MKMaher Kharrat
Maher Kharrat
KBKhadija Bellil
Khadija Bellil
The microsatellite stable with epithelial to mesenchymal transition (MSS/EMT) subtype includes some of the most aggressive gastric tumors with the worst prognosis. The purpose of this study is to characterize the MSS/EMT subtype by investigating potential associations with clinicopathologic features and specific elements of the tumor microenvironment: tumor-infiltrating lymphocytes and tumor budding. From a retrospectively collected bi-centric cohort, we first selected microsatellite stable samples and then assessed the immunohistochemical expression of E-cadherin, β-catenin, and zinc finger E-box binding homeobox 1 to identify the epithelial to mesenchymal transition. Our findings revealed that the MSS/EMT subtype represented 43% of our series, which was a high prevalence compared to previous studies. This subtype included patients who were significantly younger than non-MSS/EMT patients ( p =  .017). It was associated with diffuse and mixed-type histology ( p =  .047) and with nonconventional carcinomas ( p =  .023). The MSS/EMT did not correlate with the advanced stage. Regarding the tumor microenvironment elements, the MSS/EMT subtype was associated with low density of tumor-infiltrating lymphocytes ( p < 10 −3 ), while no association was found with tumor budding score. In conclusion, the highly prevalent and distinct MSS/EMT gastric cancer subtype features low tumor-infiltrating lymphocyte density, suggesting an immunosuppressive tumor microenvironment and therapy resistance.

23 December 2022 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
MAMarwa Aloui
Marwa Aloui
SRSarra Ben Rejeb
Sarra Ben Rejeb
MBManel Boudokhan
Manel Boudokhan
ADAmen Dhaoui
Amen Dhaoui
MRMajdi Ben Romdhane
Majdi Ben Romdhane
SBSyrine Belakhal
Syrine Belakhal
Objective: Multiple myeloma is a clonal plasma cell proliferation often causing bone lytic lesions. It is sometimes challenging to differentiate these lytic lesions associated with multiple myeloma from bone destruction due to a metastasis. Although coexistence of solid tumors and plasma cell myeloma in one patient has been described, synchronous skeletal metastases from both neoplasms occurring in the same bone lesion is exceptional. Indeed, only one case has been reported in the literature. Case presentation: Herein, we report a case involving a 68-year-old Caucasian male patient admitted to our department for coronavirus disease 2019 infection with incidental finding of multiple lytic bone lesions during hospitalization. Laboratory tests revealed an increased immunoglobulin G kappa M protein and high levels of carbohydrate antigen 19-9. Bone marrow aspiration showed increased atypical plasma cells consistent with multiple myeloma. Percutaneous image-guided biopsy of one of the osteolytic lesions was performed. Pathological examination identified both plasma cell neoplasm and poorly differentiated metastatic carcinoma within the same bone lytic lesions. Conclusion: The present case raises awareness among clinicians and pathologists that clinical and radiologic suspicion of multiple myeloma may be within the spectrum of second primary malignancies.

1 January 2021
Verified
Journal Article
Open access
SRSarra Ben Rejeb
Sarra Ben Rejeb
DBDorsaf Beltaifa
Dorsaf Beltaifa
AGAmen Ghozzi
Amen Ghozzi
KBKhadija Bellil
Khadija Bellil
STSenda Turki
Senda Turki
Ep-CAM, is a cell adhesion glycoprotein located on the basolateral cell membrane surface and in the cytoplasm of most normal epithelial cells. It has also been described to be expressed in several malignancies such as lung, digestive, prostate and renal carcinomas suggesting it has a potential role in carcinogenesis. In thyroid carcinoma, Ep-CAM expression has rarely been studied especially in papillary thyroid carcinoma. We sought to describe and compare the immunohistochemical expression of MOC31 in papillary thyroid carcinoma and in non invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). We have retrospectively collected 33 cases of PTC diagnosed in the pathology department of the Security forces hospital during a period of 13 years (2008-2021). We have microscopically reviewed all cases and reclassified 9 of 33 cases as NIFTP. An immunohistochemical automated study have been performed with MOC-31 antibody. The immunostaining was considered positive when it was membranous and/or cytoplasmic. The intensity of staining was scored as weak (score 1), moderate (score 2), and strong (score 3). We have used an immunoscore for assessing level of expression of MOC31 as follows: 0 for <5% of positive cells, 1 for 5-30%, 2 for 31-50%, 3 for 51-70%.The total score resulted by summing the percentage score with the intensity score; the final score was varying from 0 to 7, considered low between 1-4 and high 5-7. The mean age of patients was 45,2 years-old for PTC cases and 48,1 years-old for NIFTP cases. A net female predominance was found in both groups (male to female ratio of respectively 0,4 and 0,3). MOC31 expression was found in 19 cases of PTC with a percentage of positive cells varying from 5 to 90%. Percentage of positive cells was variable from 5 to 90%. The immunoscore for positive cells was: 0 in 5/24cases, 1 in 4/24cases, 3 in 9/24cases and 4 in 6/24cases. The intensity of staining was assessed score2 (moderate) in 8 cases and score 3 (high) in 7cases (Figure1-2). Final MOC31 staining score was low in 37,5% (9/24) and high in 62.5% (15/24). Patients with advanced pt2-pt3 stages mostly showed high score of MOC31 staining (61,5%).One case was associated with lymph node involvement and was of a high score. 6 cases showed vascular invasion and was of high MOC31 score. MOC31 was expressed in all NIFTP cases with variable proportion of positive cells (5%-80%). The immunoscore for positive cells was: 0 in 1/9cases, 1 in 2/9cases, 2 in 3/9cases, 3 in 1/9cases and 4 in 2/9cases. The intensity of staining was assessed score 1 (weak) in one case, score 2 (moderate) in 6 cases and score 3 (high) in one case (Figure3-4). The final combined score was low in 66,7 (6/9) and high in 33,3% (3/9). Our study revealed different immunohistochemical profile of MOC31 in benign and malignant tumors. It has somewhat a diffuse and marked staining in the first group. The changes of MOC31 location as well as its score of staining in PTC and NIFTP could hence be helpful in the differential diagnosis. Our findings also support the potential prognostic value of this molecule that deserves further investigations.

1 April 2025 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
SRSarra Ben Rejeb
Sarra Ben Rejeb
MAMariem Ayari
Mariem Ayari
SDSoumaya Debbiche
Soumaya Debbiche
HCHela Cherif
Hela Cherif
MCMehdi Charfi
Mehdi Charfi
TJTaieb Jomni
Taieb Jomni
Introduction and importance: Sarcoidosis is a multisystemic, non-caseating granulomatous disease of unknown etiology, predominantly affecting the lungs and lymph nodes. Gastrointestinal involvement, especially in the gallbladder, is rare. Here, we presented a unique case of granulomatous lymphadenitis in a gallbladder-associated lymph node, revealing systemic sarcoidosis. Case presentation: A 70-year-old woman with a history of atrial fibrillation, hypertension, and autoimmune gastritis presented with right upper quadrant pain and vomiting. Ultrasound showed multiple gallstones, and laboratory tests revealed elevated liver enzymes. Cholecystectomy was performed, and histopathological examination of the gallbladder specimen revealed granulomas suggestive of sarcoidosis. The patient had a two-month history of dyspnea, cough, and sputum production. Radiologic imaging revealed interstitial lung disease and mediastinal lymphadenopathy, supporting a diagnosis of sarcoidosis. Laboratory tests confirmed elevated ACE levels, and tuberculosis was ruled out. Clinical discussion: Sarcoidosis is often asymptomatic or misdiagnosed due to its variable presentations. Involvement of the gallbladder or biliary lymph nodes is exceedingly rare, typically discovered incidentally during cholecystectomy. Histological findings of non-caseating granulomas with asteroid and Schaumann bodies are indicative of sarcoidosis. In endemic regions, tuberculosis must be excluded. Clinical reassessment is crucial to detect symptoms of sarcoidosis following incidental findings. Conclusion: This rare presentation of sarcoidosis in a biliary lymph node highlights the importance of thorough pathological examination in cases of gallbladder abnormalities with lymph node involvement. A non-caseating granulomas should raise suspicion of sarcoîdosis even in asymptomatic patients. Highlights: